Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints

[1]  S. Patten,et al.  Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription , 2019, JAMA neurology.

[2]  J. Aarseth,et al.  Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II–IV , 2018, Journal of Neuro-Oncology.

[3]  S. Shete,et al.  Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case–control study , 2018, Journal of Neurology.

[4]  P. Calabresi,et al.  Neuropsychiatric adverse events of antiepileptic drugs in brain tumour‐related epilepsy: an Italian multicentre prospective observational study , 2017, European journal of neurology.

[5]  G. Avanzini,et al.  Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center , 2017, PloS one.

[6]  L. Hirsch,et al.  Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy , 2017, Epilepsy & Behavior.

[7]  M. Mula,et al.  Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study , 2017, Journal of Neurology.

[8]  M. Gilbert,et al.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. , 2016, Neuro-oncology.

[9]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[10]  M. Taphoorn,et al.  Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. , 2015, Neuro-oncology practice.

[11]  C. Vecht,et al.  Seizure prognosis in brain tumors: new insights and evidence-based management. , 2014, The oncologist.

[12]  E. Perucca.  Optimizing antiepileptic drug treatment in tumoral epilepsy , 2013, Epilepsia.

[13]  P. Brown,et al.  Depression in glioma: a primer for clinicians and researchers , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  L. Douw,et al.  Levetiracetam improves verbal memory in high-grade glioma patients. , 2013, Neuro-oncology.

[15]  M. Klein.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities. , 2012, Neuro-oncology.

[16]  L. Fallowfield,et al.  Systematic review of supportive care needs in patients with primary malignant brain tumors. , 2012, Neuro-oncology.

[17]  Anne Sabers,et al.  Effect of Antiepileptic Drugs on Cognitive Function in Individuals with Epilepsy , 2012, Drugs.

[18]  A. Carson,et al.  Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Carson,et al.  Depression in cerebral glioma patients: a systematic review of observational studies. , 2011, Journal of the National Cancer Institute.

[20]  L. Douw,et al.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up , 2009, The Lancet Neurology.

[21]  C. Helmstaedter,et al.  The effects of levetiracetam on cognition: A non-interventional surveillance study , 2008, Epilepsy & Behavior.

[22]  Ian Shrier,et al.  Reducing bias through directed acyclic graphs , 2008 .

[23]  Steve S. Chung,et al.  Comparative retention rates and long-term tolerability of new antiepileptic drugs , 2007, Seizure.

[24]  C. Vecht,et al.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management , 2007, The Lancet Neurology.

[25]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[26]  D. Lyon,et al.  Symptom clusters in patients with high-grade glioma. , 2007, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[27]  Margaret Wrensch,et al.  Epidemiology and molecular pathology of glioma , 2006, Nature Clinical Practice Neurology.

[28]  D. Lemke.  Epidemiology, Diagnosis, and Treatment of Patients With Metastatic Cancer and High-grade Gliomas of the Central Nervous System , 2004, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[29]  Martin Klein,et al.  Cognitive deficits in adult patients with brain tumours , 2004, The Lancet Neurology.

[30]  A. Aldenkamp,et al.  Mood effects of antiepileptic drugs , 2004, Epilepsy & Behavior.

[31]  Martin Klein,et al.  Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life , 2003, Annals of neurology.

[32]  J. Jolles,et al.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study , 2002, The Lancet.

[33]  M. Taphoorn,et al.  Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Jon A. Mukand,et al.  Incidence of Neurologic Deficits and Rehabilitation of Patients with Brain Tumors , 2001, American journal of physical medicine & rehabilitation.

[35]  R. Lennox,et al.  Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale , 2001, Epilepsy Research.

[36]  L. Recht,et al.  Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors , 2000, Neurology.

[37]  K. Skullerud,et al.  Prevalence and prognostic significance of epilepsy in patients with gliomas. , 1998, European journal of cancer.

[38]  H. Meinardi,et al.  Drug load in clinical trials: A neglected factor , 1997, Clinical pharmacology and therapeutics.

[39]  J. Ormel,et al.  A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects , 1997, Psychological Medicine.

[40]  E. Bruera,et al.  Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. , 1995, Journal of pain and symptom management.

[41]  Ron D. Hays,et al.  User's Manual for the Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life , 1995 .

[42]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.